Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Acquired by Bessemer Group Inc.

Bessemer Group Inc. increased its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 10,053.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 295,050 shares of the company’s stock after acquiring an additional 292,144 shares during the period. Bessemer Group Inc.’s holdings in Prestige Consumer Healthcare were worth $23,041,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Kestra Investment Management LLC bought a new position in shares of Prestige Consumer Healthcare during the 4th quarter valued at about $27,000. CIBC Private Wealth Group LLC grew its position in Prestige Consumer Healthcare by 48.9% in the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company’s stock worth $34,000 after buying an additional 152 shares during the last quarter. Headlands Technologies LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at $40,000. GAMMA Investing LLC boosted its stake in shares of Prestige Consumer Healthcare by 18.9% during the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after acquiring an additional 220 shares in the last quarter. Finally, Huntington National Bank raised its position in shares of Prestige Consumer Healthcare by 133.2% during the fourth quarter. Huntington National Bank now owns 1,481 shares of the company’s stock worth $116,000 after purchasing an additional 846 shares during the period. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Price Performance

PBH opened at $80.66 on Friday. The stock has a fifty day moving average price of $84.43 and a 200 day moving average price of $79.75. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare Inc. has a 1 year low of $62.35 and a 1 year high of $90.04. The stock has a market cap of $4.00 billion, a price-to-earnings ratio of 18.89, a PEG ratio of 2.69 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. Analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Analysts Set New Price Targets

PBH has been the topic of several recent analyst reports. DA Davidson boosted their price objective on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a report on Friday, February 7th. StockNews.com lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday. Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Oppenheimer boosted their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research note on Thursday, February 13th. Finally, Royal Bank of Canada raised their target price on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a “sector perform” rating in a research report on Friday, March 21st. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $93.33.

Insider Activity

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction on Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the transaction, the senior vice president now directly owns 17,157 shares of the company’s stock, valued at $1,544,130. This represents a 8.91 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.60% of the stock is owned by insiders.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.